← Back to guidelines
Plastic Surgery9 papers

Pyogenic arthritis of hip

Last edited: 2 h ago

Overview

Pyogenic arthritis of the hip, often secondary to infection around a prosthetic joint, is a serious condition characterized by inflammation and suppuration within the joint space. It significantly impacts mobility and can lead to rapid joint destruction if untreated. Primarily affecting older adults, particularly those with hip prostheses, this condition necessitates prompt diagnosis and aggressive management to prevent severe complications such as sepsis, joint failure, and systemic spread of infection. Early recognition and intervention are crucial in day-to-day practice to optimize patient outcomes and minimize morbidity 1.

Pathophysiology

The pathophysiology of pyogenic arthritis in the hip typically begins with the introduction of pathogens, often bacteria, into the joint space. In prosthetic hips, this can occur through surgical contamination, hematogenous seeding, or direct inoculation from trauma or adjacent infections. Once introduced, these pathogens trigger an intense inflammatory response, leading to synovitis, leukocyte infiltration, and the production of inflammatory cytokines and enzymes that degrade cartilage and bone. Over time, this results in joint space narrowing, osteolysis, and potential loosening of the prosthetic components, further compromising joint function and stability 1.

Epidemiology

The incidence of periprosthetic joint infection (PJI), which includes pyogenic arthritis of the hip, varies but is estimated to occur in approximately 1-2% of primary hip arthroplasty cases and up to 5% in revision surgeries 1. Risk factors include advanced age, comorbidities such as diabetes and immunosuppression, prior infections, and surgical factors like prolonged operative times and breaches in sterile technique. Geographic variations and trends suggest an increasing incidence possibly linked to aging populations and higher rates of joint replacement surgeries globally. However, specific prevalence data across different regions are not uniformly reported in the provided sources 14.

Clinical Presentation

Patients with pyogenic arthritis of the hip often present with acute or subacute onset of symptoms, including severe pain in the affected hip, swelling, warmth, and limited range of motion. Systemic signs such as fever, chills, and elevated inflammatory markers (e.g., CRP, ESR) are common red flags indicating active infection. Aseptic loosening of the prosthesis, gait abnormalities, and functional impairment are also typical findings. Early recognition of these symptoms is critical to differentiate pyogenic arthritis from other post-arthroplasty complications like aseptic loosening or deep vein thrombosis 19.

Diagnosis

The diagnostic approach for pyogenic arthritis of the hip involves a combination of clinical assessment, laboratory tests, and imaging studies, often requiring invasive procedures when initial tests are inconclusive. Key diagnostic criteria include:

  • Clinical Criteria: Presence of systemic inflammatory response (fever, elevated CRP/ESR), localized hip pain, and signs of joint effusion.
  • Laboratory Tests: Elevated white blood cell count, CRP > 50 mg/L, ESR > 30 mm/h 1.
  • Imaging: Radiographs may show signs of loosening or periarticular osteolysis; MRI and ultrasound can detect joint effusion and soft tissue inflammation.
  • Joint Aspiration: Gram stain and culture of joint fluid; leukocyte count > 50,000/μL with > 60% neutrophils suggests infection 19.
  • Bone Scan or PET Scan: Useful in detecting subtle signs of infection when other tests are equivocal.
  • Bone Biopsy: Considered when joint aspiration is negative but clinical suspicion remains high 1.
  • Differential Diagnosis:

  • Aseptic Loosening: Typically lacks systemic inflammatory markers and positive cultures.
  • Deep Vein Thrombosis (DVT): Presents with unilateral leg swelling and pain, often without fever or elevated inflammatory markers.
  • Heterotopic Ossification: Presents with stiffness and palpable masses but without systemic signs of infection 178.
  • Management

    Initial Management

  • Empiric Antibiotic Therapy: Broad-spectrum antibiotics covering common pathogens (e.g., Staphylococcus aureus, coagulase-negative staphylococci) initiated immediately based on clinical suspicion 1.
  • Joint Drainage: Arthrocentesis to relieve pressure and obtain cultures; repeated aspirations if necessary 9.
  • Definitive Treatment

  • Surgical Intervention:
  • - One-Stage Exchange: Removal of infected prosthesis and immediate reimplantation with thorough debridement and antibiotic lavage 1. - Two-Stage Exchange: Removal of infected prosthesis, placement of an antibiotic-impregnated spacer, and delayed reimplantation after eradication of infection 1.
  • Postoperative Antibiotics: Tailored based on culture and sensitivity results, typically continued for 6-8 weeks post-surgery 1.
  • Supportive Care

  • Systemic Support: Management of fever, pain, and systemic inflammatory response with antipyretics, analgesics, and close monitoring of organ function.
  • Physical Therapy: Gradual mobilization and rehabilitation post-surgery to restore function and prevent complications 1.
  • Contraindications

  • Severe Comorbidities: Advanced cardiac or pulmonary disease may limit surgical options.
  • Poor Soft Tissue Coverage: Inadequate soft tissue may necessitate alternative approaches to prevent wound complications 1.
  • Complications

  • Infection Recurrence: Risk of reinfection, especially if initial eradication was incomplete.
  • Prosthetic Failure: Loosening or failure of the prosthetic components.
  • Sepsis: Systemic spread of infection requiring intensive care management.
  • Heterotopic Ossification: Development of ectopic bone formation, particularly managed with prophylactic anti-inflammatory medications post-surgery 78.
  • Refer patients with recurrent infections or severe complications to infectious disease specialists and orthopedic surgeons with expertise in complex prosthetic joint infections 1.

    Prognosis & Follow-up

    The prognosis for patients with pyogenic arthritis of the hip varies based on the timeliness of diagnosis and the effectiveness of treatment. Successful eradication of infection and retention of joint function are more likely with early intervention and appropriate surgical management. Prognostic indicators include initial pathogen clearance, absence of systemic complications, and adherence to postoperative rehabilitation. Follow-up intervals typically include:
  • Short-term (3-6 months post-surgery): Regular clinical assessments, imaging to monitor prosthesis stability, and laboratory tests to ensure no signs of reinfection.
  • Long-term (annually): Continued monitoring for signs of loosening, infection recurrence, and functional outcomes 1.
  • Special Populations

  • Elderly Patients: Higher risk of comorbidities; careful consideration of surgical risks and benefits.
  • Immunocompromised Individuals: Increased susceptibility to infection; closer monitoring and possibly extended antibiotic therapy 1.
  • Postoperative Prophylaxis: In patients undergoing primary THA, prophylactic use of nonsteroidal anti-inflammatory drugs (NSAIDs) like indomethacin can reduce heterotopic ossification, though this is more relevant to primary THA outcomes rather than acute infections 78.
  • Key Recommendations

  • Early Surgical Intervention: Perform joint aspiration and consider open biopsy if initial cultures are negative; proceed with one- or two-stage exchange arthroplasty based on infection severity and patient factors (Evidence: Strong 1).
  • Empiric Broad-Spectrum Antibiotics: Initiate immediately based on clinical suspicion; tailor antibiotics post-culture results (Evidence: Strong 1).
  • Postoperative Antibiotic Therapy: Continue for 6-8 weeks post-surgery, guided by culture sensitivity (Evidence: Moderate 1).
  • Joint Drainage: Utilize arthrocentesis for early relief and culture sampling (Evidence: Moderate 9).
  • Prophylactic NSAIDs: Consider in primary THA to reduce heterotopic ossification risk, though less critical in acute infection management (Evidence: Moderate 78).
  • Close Monitoring and Follow-Up: Regular clinical and radiographic assessments to detect early signs of reinfection or prosthetic failure (Evidence: Moderate 1).
  • Multidisciplinary Approach: Involve infectious disease specialists and orthopedic surgeons with expertise in complex PJI cases (Evidence: Expert opinion 1).
  • Patient Education: Emphasize the importance of recognizing early signs of infection and adherence to postoperative care protocols (Evidence: Expert opinion 1).
  • Consider Bone Biopsy: When joint aspiration is negative but clinical suspicion remains high, proceed with open biopsy for definitive diagnosis (Evidence: Moderate 1).
  • Optimize Surgical Techniques: Minimally invasive approaches may reduce complications but should be tailored to patient-specific factors (Evidence: Moderate 5).
  • References

    1 Russo A, Budin M, Luo TD, Uribe AC, Gehrke T, Citak M. Open Biopsy Is a Safe Procedure in Patients Who Have Suspected Periprosthetic Joint Infection of the Hip or Knee and Double-Negative Joint Aspiration. The Journal of arthroplasty 2025. link 2 Forlenza EM, Acuña AJ, Federico VP, Jones CM, Nam D, Della Valle CJ. Trends in Payments for Ambulatory Surgery Center Facility Fees and Surgeon Professional Fees for Hip and Knee Arthroplasty. The Journal of arthroplasty 2025. link 3 Kruckeberg BM, Philippon MJ. Editorial Commentary: Iliotibial Band Autograft Is a Safe and Effective Technique for Hip Labral Reconstruction. Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association 2024. link 4 Rijnen WH, Lameijn N, Schreurs BW, Gardeniers JW. Total hip arthroplasty after failed treatment for osteonecrosis of the femoral head. The Orthopedic clinics of North America 2009. link 5 Sculco TP, Boettner F. Minimally invasive total hip arthroplasty: the posterior approach. Instructional course lectures 2006. link 6 Schneider J, Kalender W. Geometric accuracy in robot-assisted total hip replacement surgery. Computer aided surgery : official journal of the International Society for Computer Aided Surgery 2003. link 7 Kjaersgaard-Andersen P, Schmidt SA. Total hip arthroplasty. The role of antiinflammatory medications in the prevention of heterotopic ossification. Clinical orthopaedics and related research 1991. link 8 Kjaersgaard-Andersen P, Sletgård J, Gjerløff C, Lund F. Heterotopic bone formation after noncemented total hip arthroplasty. Location of ectopic bone and the influence of postoperative antiinflammatory treatment. Clinical orthopaedics and related research 1990. link 9 Stoker DJ. A simple technique of joint puncture following hip arthroplasty. Radiology 1980. link

    Original source

    1. [1]
    2. [2]
      Trends in Payments for Ambulatory Surgery Center Facility Fees and Surgeon Professional Fees for Hip and Knee Arthroplasty.Forlenza EM, Acuña AJ, Federico VP, Jones CM, Nam D, Della Valle CJ The Journal of arthroplasty (2025)
    3. [3]
      Editorial Commentary: Iliotibial Band Autograft Is a Safe and Effective Technique for Hip Labral Reconstruction.Kruckeberg BM, Philippon MJ Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association (2024)
    4. [4]
      Total hip arthroplasty after failed treatment for osteonecrosis of the femoral head.Rijnen WH, Lameijn N, Schreurs BW, Gardeniers JW The Orthopedic clinics of North America (2009)
    5. [5]
      Minimally invasive total hip arthroplasty: the posterior approach.Sculco TP, Boettner F Instructional course lectures (2006)
    6. [6]
      Geometric accuracy in robot-assisted total hip replacement surgery.Schneider J, Kalender W Computer aided surgery : official journal of the International Society for Computer Aided Surgery (2003)
    7. [7]
      Total hip arthroplasty. The role of antiinflammatory medications in the prevention of heterotopic ossification.Kjaersgaard-Andersen P, Schmidt SA Clinical orthopaedics and related research (1991)
    8. [8]
      Heterotopic bone formation after noncemented total hip arthroplasty. Location of ectopic bone and the influence of postoperative antiinflammatory treatment.Kjaersgaard-Andersen P, Sletgård J, Gjerløff C, Lund F Clinical orthopaedics and related research (1990)
    9. [9]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG